It’s not just money that is lacking. Successful development of medical therapeutics in Japan ー including vaccines ー takes transparency and ethical policies.
Belatedly, Japan is progressing with more support for vaccine research and development, examination and examination for safety and efficacy. Can it catch up?
In Japan, Daiichi Sankyo began developing an mRA vaccine about the same time as Pfizer and Moderna, but the know-how to connect this society was lacking.
A new command center is setting out to promote the development of domestic vaccines through creation of a more supportive research and funding environment.